<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
BLUE
Bluebird Bio
$
()


  • Pfizer withdrawal of Oxbryta raises questions, sends Fulcrum stock higher

    9/26/2024 - 10:22am
  • Leerink sees little impact to genetic medicines from Pfizer's Oxbryta withdrawal

    9/26/2024 - 09:51am
  • Bluebird Bio price target lowered by $1 at Wells Fargo, here's why

    9/25/2024 - 06:19am
  • Bluebird Bio to reduce workforce by 25% in restructuring

    9/24/2024 - 07:08am
  • Bluebird Bio receives noncompliance notices from Nasdaq

    8/23/2024 - 16:12pm
  • Bluebird Bio price target lowered by $1 at BofA, here's why

    8/15/2024 - 06:39am
  • Bluebird Bio price target lowered by $1 at Baird, here's why

    8/15/2024 - 06:36am
  • Bluebird Bio price target lowered by $4 at Barclays, here's why

    8/15/2024 - 05:42am
  • Bluebird Bio just downgraded at JPMorgan, here's why

    8/14/2024 - 16:26pm
  • Bluebird Bio reports Q2 revenue $16.1M vs .$6.9M last year

    8/14/2024 - 07:27am
  • Bluebird Bio sees recognizing revenue from LYFGENIA infusion in Q3 or Q4

    8/14/2024 - 07:25am
  • JPMorgan biotech analysts hold an analyst/industry conference call

    6/17/2024 - 12:18pm
  • Bluebird Bio appoints James Sterling CFO succeeding Chris Krawtschuk

    5/29/2024 - 07:07am
  • Largest borrow rate increases among liquid names

    5/24/2024 - 08:45am
  • Bluebird Bio reports Q1 revenue$ 18.6M vs. $2.4M last year

    5/9/2024 - 07:32am
dynamic_feed Breaking News